Uttranchal Pharmaceuticals Private Limited - Company Profile

It is a pharma private limited company based in New Delhi, Delhi, India, established in 2005.
2005 New Delhi, Delhi, India Active
Last Updated:
Access Report
About Uttranchal Pharmaceuticals Private Limited

Uttranchal Pharmaceuticals Private Limited, a active private limited company, was established on 08 July 2005 in New Delhi, Delhi, India. Engaging in drug formulation & development within the manufacturing sector, it holds CIN: U24232DL2005PTC138489. Registered under ROC Roc Delhi. it is unlisted. It has an authorized capital of ₹2.15 Cr and a paid-up capital of ₹2.15 Cr.

It upholds a compliant status. Its leadership includes Kathiravanathan (Managing Director), Nitha (Director). Past directors included Suresh Kumar Khurana, Krishan Kumar Nangia, Manoj Kumar Ahuja. It holds ₹8.35 Cr open charges and ₹5.05 Cr settled loans. Its latest AGM occurred on 30 September 2025, with the balance sheet filed on 31 March 2025. It is based at B-737 Gali No.24, Sant Nagar Burari, New Delhi, Delhi, 110084.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U24232DL2005PTC138489

  • Registration Number

    138489

  • Incorporation Date

    08 July 2005

  • Authorized Capital

    ₹2.15 Cr

  • Paid-Up Capital

    ₹2.15 Cr

  • ROC Code

    Roc Delhi

  • Listing Status

    Unlisted

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 2.15 Cr
  • Paid Up Capital ₹ 2.15 Cr
  • Company Age 20 Year, 7 Months
  • Last Filing with ROC 31 Mar 2025
  • Open Charges ₹ 8.35 Cr
  • Satisfied Charges ₹ 5.05 Cr
  • Revenue Growth **** 69.90%
  • Profit Growth **** -13.26%
  • Ebitda **** 28.21%
  • Net Worth 4.08%
  • Total Assets **** 51.98%
Company report

Uttranchal Pharmaceuticals Private Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Uttranchal Pharmaceuticals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report
Who are the key members and board of directors at Uttranchal Pharmaceuticals Private Limited?
Current Directors
Name Designation Appointment Date Status
Kathiravanathan Managing Director 20 Jan 2015 Current
Nitha Director 20 Jan 2015 Current
Past Directors
Name Designation Cessation Status
Pramod Abcsdd Director 24 Feb 2015 Past
Pramod Abcsdd Director 09 Feb 2015 Past
Pramod Abcsdd Director 09 Feb 2015 Past
Pramod Abcsdd Director 09 Feb 2015 Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Uttranchal Pharmaceuticals.

Uttranchal Pharmaceuticals Private Limited, for the financial year ended 2024, experienced significant growth in revenue, with a 69.9% increase. The company also saw a substantial fall in profitability, with a 13.26% decrease in profit. The company's net worth moved up by a moderate rise of 4.08%.

Uttranchal Pharmaceuticals revenue growth over time
Uttranchal Pharmaceuticals profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
 69.90%
*******
*******
*******
*******
Revenue from Operations
*******
 69.88%
*******
*******
*******
*******
Total Assets
*******
 51.98%
*******
*******
*******
*******
Profit or Loss
*******
 -13.26%
*******
*******
*******
*******
Net Worth
*******
 4.08%
*******
*******
*******
*******
EBITDA
*******
 28.21%
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Uttranchal Pharmaceuticals?

Unlock access to Uttranchal Pharmaceuticals's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

Charges (Loans)
Open Charges

₹83,500,000.00

Satisfied Charges

₹50,512,000.00

Charges Breakdown by Lending Institutions
  • Others : 8.35 Cr
Latest Charge Details
Date Lender Amount Status
28 May 2025 Others ₹8.35 Cr Open
27 May 2023 Axis Bank Limited ₹2.70 Cr Satisfied
17 May 2022 Hdfc Bank Limited ₹1.42 Cr Satisfied
16 Jun 2020 Others ₹1.31 M Satisfied
15 Apr 2015 Punjab National Bank ₹8.00 M Satisfied

Explore comprehensive loan charge details -

How Many Employees Work at Uttranchal Pharmaceuticals?

Unlock and access historical data on people associated with Uttranchal Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Uttranchal Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Uttranchal Pharmaceuticals's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Uttranchal Pharmaceuticals
Recent Activity within the Organization
  • Annual General Meeting

    The activity Uttranchal Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records. was completed.

  • Charges

    A charge registered on 27 May 2023 via Charge ID 100730026 with Axis Bank Limited was fully satisfied on 12 Jun 2025. was recorded as a recent event.

  • Charges

    Progress on A charge with Others amounted to Rs. 8.35 Cr with Charge ID 101112591 was registered on 28 May 2025. was documented.

  • Balance Sheet

    Uttranchal Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Delhi. was recorded as a recent event.

  • Charges

    Progress on A charge registered on 17 May 2022 via Charge ID 100576801 with Hdfc Bank Limited was fully satisfied on 15 Jun 2023. was documented.

  • Charges

    A charge with Axis Bank Limited amounted to Rs. 2.70 Cr with Charge ID 100730026 was registered on 27 May 2023. was recorded as a recent event.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Uttranchal Pharmaceuticals Private Limited?

The CIN of Uttranchal Pharmaceuticals Private Limited is U24232DL2005PTC138489.

Where is Uttranchal Pharmaceuticals Private Limited headquartered?

Uttranchal Pharmaceuticals Private Limited is headquartered at B-737 Gali No.24, Sant Nagar Burari, New Delhi, Delhi, 110084.

When was Uttranchal Pharmaceuticals Private Limited incorporated?

Uttranchal Pharmaceuticals Private Limited was incorporated on 08 July 2005.

Who are the current directors of Uttranchal Pharmaceuticals Private Limited?

The current directors of Uttranchal Pharmaceuticals Private Limited are

What is the primary industry of Uttranchal Pharmaceuticals Private Limited?

The primary industry of Uttranchal Pharmaceuticals Private Limited is Manufacturing.

Is Uttranchal Pharmaceuticals Private Limited a listed company?

Uttranchal Pharmaceuticals Private Limited is unlisted.

What is the capital structure of Uttranchal Pharmaceuticals Private Limited?

The authorized capital of Uttranchal Pharmaceuticals Private Limited is ₹2.15 Cr, and the paid-up capital is ₹2.15 Cr.

What is the compliance status of Uttranchal Pharmaceuticals Private Limited?

The compliance status of Uttranchal Pharmaceuticals Private Limited is Compliant.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available